Singular Genomics Systems, Inc. (OMIC) Reports In-Line Q4 EPS
Singular Genomics Systems, Inc. (NASDAQ: OMIC) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $829.67 thousand.
For earnings history and earnings-related data on Singular Genomics Systems, Inc. (OMIC) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share